(Q33290679)

English

IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.

scientific article

Statements

IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit